摘要
目的:评价粗针身柱穴透刺治疗帕金森病肌僵直的疗效。方法:将61例帕金森病患者随机分为粗针组和美多巴组,美多巴组服用美多巴1次125mg,每日4次;粗针组在服用同样剂量美多巴的同时,增加粗针从身柱穴沿督脉向下透刺,每周3次。结果:粗针组在疗后30 d、90 d时UPDRS和TAS评分均逐渐下降,有统计学意义;在疗后180 d回访时评分较疗前有所上升,提示症状有加重,但这3个评价时间点均优于单纯口服美多巴的对照组(P<0.01)。说明粗针具有改善帕金森病肌僵直的明显疗效,优于美多巴组。结论:粗针可以明显改善帕金森病肌僵直,具有积极治疗帕金森病的作用。
Objective :To evaluate the effect of treating rigidity of Parkinson Disease (PD) by penetration needling of thick needle from Shenzhu Point. Method: We chose 61 cases suffering from PD, which were randomly divided into two groups, thick needle group and Madopar medicine group. Madopar medicine group took Madopar medicine once 125 mg and four times a day. Thick needle group took the same dose of Madopar medicine, together with thick needle from Shenzhu Point downward the Du longitude penetration needling, three times a week. Rustles:We found that the scores of thick needle group'UPDRS and TAS after treatments were all lower gradually in first and third month, while there was sta- tistical significance. The scores of thick needle groupJUPDRS and TAS after treatment were somewhat higher in the sixth return visit, indicating that symptom was worsening, hut efficacy was better in the three point - in - time than controlling group by only taking Madopar medicine (P 〈 0.01 ). It shows that thick needle which can improve rigidity of Parkinson disease has significantly efficacy than Madopar medicine group. Conclusion:Thick needle can significantly improve rigidity of Parkinson disease and plays a positive role in the treatment.
出处
《中华中医药学刊》
CAS
2013年第12期2745-2747,共3页
Chinese Archives of Traditional Chinese Medicine
基金
浙江省中医药管理局资助项目(2010ZA024)
关键词
粗针
帕金森病
肌僵直
thick needle
Parkinson disease
rigidity